Terms: = Head and neck cancer AND SEPT9, PNUTL4, 10801, ENSG00000184640, MSF1, KIAA0991, AF17q25, MSF, SeptD1, SINT1 AND Prognosis
10 results:
1. Epigenetics in the diagnosis and prognosis of head and neck cancer: A systematic review.
Lim I; Tan J; Alam A; Idrees M; Brenan PA; Coletta RD; Kujan O
J Oral Pathol Med; 2024 Feb; 53(2):90-106. PubMed ID: 38316046
[TBL] [Abstract] [Full Text] [Related]
2. Circulating Cell-Free sept9 DNA Methylation in Blood Is a Biomarker for Minimal Residual Disease Detection in head and neck Squamous Cell Carcinoma Patients.
Dietrich D; Weider S; de Vos L; Vogt TJ; Färber M; Zarbl R; Hunecke A; Glosch AK; Gabrielpillai J; Bootz F; Bauernfeind FG; Kramer FJ; Kristiansen G; Brossart P; Strieth S; Franzen A
Clin Chem; 2023 Sep; 69(9):1050-1061. PubMed ID: 37477541
[TBL] [Abstract] [Full Text] [Related]
3. Maxillary Sinus Floor Infiltration: Results From a Series of 118 Maxillary Sinus cancers.
Arosio AD; Turri-Zanoni M; Sileo G; Tirloni M; Volpi L; Lambertoni A; Margherini S; Mercuri A; Battaglia P; Cherubino M; Castelnuovo P; Bignami M
Laryngoscope; 2022 Jan; 132(1):26-35. PubMed ID: 34156096
[TBL] [Abstract] [Full Text] [Related]
4. [Prognostic and predictive methylation biomarkers in HNSCC : Epigenomic diagnostics for head and neck squamous cell carcinoma (HNSCC)].
Franzen A; Bootz F; Dietrich D
HNO; 2020 Dec; 68(12):911-915. PubMed ID: 32613323
[TBL] [Abstract] [Full Text] [Related]
5. sept9_v2, frequently silenced by promoter hypermethylation, exerts anti-tumor functions through inactivation of Wnt/β-catenin signaling pathway via miR92b-3p/FZD10 in nasopharyngeal carcinoma cells.
Jiang Y; Liu L; Xiang Q; He X; Wang Y; Zhou D; Zou C; Chen Q; Peng M; He J; Jiang X; Xiang T; Yang Y
Clin Epigenetics; 2020 Mar; 12(1):41. PubMed ID: 32138771
[TBL] [Abstract] [Full Text] [Related]
6. Comparison of quantification algorithms for circulating cell-free DNA methylation biomarkers in blood plasma from cancer patients.
de Vos L; Gevensleben H; Schröck A; Franzen A; Kristiansen G; Bootz F; Dietrich D
Clin Epigenetics; 2017; 9():125. PubMed ID: 29213339
[TBL] [Abstract] [Full Text] [Related]
7. Free-Circulating Methylated DNA in Blood for Diagnosis, Staging, prognosis, and Monitoring of head and neck Squamous Cell Carcinoma Patients: An Observational Prospective Cohort Study.
Schröck A; Leisse A; de Vos L; Gevensleben H; Dröge F; Franzen A; Wachendörfer M; Schröck F; Ellinger J; Teschke M; Wilhelm-Buchstab T; Landsberg J; Holdenrieder S; Hartmann G; Field JK; Bootz F; Kristiansen G; Dietrich D
Clin Chem; 2017 Jul; 63(7):1288-1296. PubMed ID: 28515105
[TBL] [Abstract] [Full Text] [Related]
8. Genome-wide screening of DNA methylation associated with lymph node metastasis in esophageal squamous cell carcinoma.
Nagata H; Kozaki KI; Muramatsu T; Hiramoto H; Tanimoto K; Fujiwara N; Imoto S; Ichikawa D; Otsuji E; Miyano S; Kawano T; Inazawa J
Oncotarget; 2017 Jun; 8(23):37740-37750. PubMed ID: 28465481
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic CpG methylation biomarkers identified by methylation array in esophageal squamous cell carcinoma patients.
Kuo IY; Chang JM; Jiang SS; Chen CH; Chang IS; Sheu BS; Lu PJ; Chang WL; Lai WW; Wang YC
Int J Med Sci; 2014; 11(8):779-87. PubMed ID: 24936140
[TBL] [Abstract] [Full Text] [Related]
10. Evaluation of T-classifications of upper gingival and hard palate carcinomas--a proposition for new criterion of T4.
Yokoo S; Umeda M; Komatsubara H; Shibuya Y; Komori T
Oral Oncol; 2002 Jun; 38(4):378-82. PubMed ID: 12076703
[TBL] [Abstract] [Full Text] [Related]
